CDT
Conduit Pharmaceuticals Inc.
NASDAQ: CDT · HEALTHCARE · BIOTECHNOLOGY
$2.25
-8.55% today
Updated 2026-04-29
Market cap
$13.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1,177.89
Dividend yield
—
52W range
$2 – $1,754
Volume
0.4M
Conduit Pharmaceuticals Inc. (CDT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $922.22M | $2.72B |
| Revenue growth (YoY) | — | — | — | — | +194.4% |
| Cost of revenue | — | — | — | $457000.00 | $1.68B |
| Gross profit | — | — | — | $-457000.00 | $1.03B |
| Gross margin | — | — | — | -0.0% | 38.0% |
| R&D | $283000.00 | $111000.00 | $90000.00 | $3.38M | $128.76M |
| SG&A | $2.89M | $3.05M | $5.17M | $12.04M | $533.37M |
| Operating income | $-3.17M | $-3.16M | $-5.26M | $-15.42M | $315.69M |
| Operating margin | — | — | — | -1.7% | 11.6% |
| EBITDA | $-3.17M | $-4.89M | $3.05M | $-15.84M | $371.52M |
| EBITDA margin | — | — | — | -1.7% | 13.7% |
| EBIT | $-488381.00 | $-3.16M | $-324000.00 | $-16.30M | $318.16M |
| Interest expense | — | $0.00 | $211000.00 | $1.51M | $46.35M |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.66M | $-4.89M | $-535000.00 | $-17.80M | $237.52M |
| Net income growth (YoY) | — | -33.6% | +89.1% | -3227.5% | +1434.2% |
| Profit margin | — | — | — | -1.9% | 8.7% |